位置:首页 > 蛋白库 > CASB_BOVIN
CASB_BOVIN
ID   CASB_BOVIN              Reviewed;         224 AA.
AC   P02666; A1YQZ8; A6N8V0; Q2TA13; Q5EEQ6; Q5EEQ7; Q6UN63; Q9BDG5; Q9TSD5;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 2.
DT   03-AUG-2022, entry version 180.
DE   RecName: Full=Beta-casein;
DE   Contains:
DE     RecName: Full=Casoparan;
DE   Contains:
DE     RecName: Full=Antioxidant peptide;
DE   Contains:
DE     RecName: Full=Casohypotensin;
DE   Flags: Precursor;
GN   Name=CSN2;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS LEU-108; PRO-152 AND LEU-153.
RX   PubMed=3814153; DOI=10.1016/0006-291x(87)90318-4;
RA   Jimenez-Flores R., Kang Y.C., Richardson T.;
RT   "Cloning and sequence analysis of bovine beta-casein cDNA.";
RL   Biochem. Biophys. Res. Commun. 142:617-621(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT HIS-82.
RA   Baev A.A., Smirnov I.K., Gorodetsky S.I.;
RT   "Primary structure of bovine beta-casein cDNA.";
RL   Mol. Biol. (Mosk.) 21:214-222(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2833669; DOI=10.1093/oxfordjournals.molbev.a040437;
RA   Stewart A.F., Bonsing J., Beattie C.W., Shah F., Willis I.M.,
RA   Mackinlay A.G.;
RT   "Complete nucleotide sequences of bovine alpha S2- and beta-casein cDNAs:
RT   comparisons with related sequences in other species.";
RL   Mol. Biol. Evol. 4:231-241(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-82.
RX   PubMed=3271384; DOI=10.1071/bi9880527;
RA   Bonsing J., Ring J.M., Stewart A.F., Mackinlay A.G.;
RT   "Complete nucleotide sequence of the bovine beta-casein gene.";
RL   Aust. J. Biol. Sci. 41:527-537(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT A3 GLN-121.
RC   TISSUE=Mammary gland;
RX   PubMed=8248100; DOI=10.1093/protein/6.7.763;
RA   Simons G., van den Heuvel W., Reynen T., Frijters A., Rutten G.,
RA   Slangen C.J., Groenen M., de Vos W.M., Siezen R.J.;
RT   "Overproduction of bovine beta-casein in Escherichia coli and engineering
RT   of its main chymosin cleavage site.";
RL   Protein Eng. 6:763-770(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS HIS-82 AND ARG-137.
RC   STRAIN=Crossbred X Angus; TISSUE=Liver;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-101.
RC   TISSUE=Mammary epithelium;
RX   PubMed=16624358; DOI=10.1016/j.rvsc.2006.02.002;
RA   Anaya-Lopez J.L., Contreras-Guzman O.E., Carabez-Trejo A.,
RA   Baizabal-Aguirre V.M., Lopez-Meza J.E., Valdez-Alarcon J.J.,
RA   Ochoa-Zarzosa A.;
RT   "Invasive potential of bacterial isolates associated with subclinical
RT   bovine mastitis.";
RL   Res. Vet. Sci. 81:358-361(2006).
RN   [8]
RP   PROTEIN SEQUENCE OF 16-224 (VARIANT A2), AND VARIANT LEU-108.
RX   PubMed=4557764; DOI=10.1111/j.1432-1033.1972.tb01722.x;
RA   Ribadeau-Dumas B., Brignon G., Grosclaude F., Mercier J.-C.;
RT   "Primary structure of bovine beta casein. Complete sequence.";
RL   Eur. J. Biochem. 25:505-514(1972).
RN   [9]
RP   PROTEIN SEQUENCE OF 16-224 (VARIANT A2).
RX   PubMed=3278933; DOI=10.1016/0014-5793(88)81138-4;
RA   Carles C., Huet J.-C., Ribadeau-Dumas B.;
RT   "A new strategy for primary structure determination of proteins:
RT   application to bovine beta-casein.";
RL   FEBS Lett. 229:265-272(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 18-57, PROTEIN SEQUENCE OF 16-224
RP   (VARIANT H), AND VARIANT D LYS-33.
RC   STRAIN=Korean; TISSUE=Milk;
RX   PubMed=10690361; DOI=10.1046/j.1365-2052.2000.00582.x;
RA   Han S.K., Shin Y.C., Byun H.D.;
RT   "Biochemical, molecular and physiological characterization of a new beta-
RT   casein variant detected in Korean cattle.";
RL   Anim. Genet. 31:49-51(2000).
RN   [11]
RP   PROTEIN SEQUENCE OF 41-71; 113-157 AND 180-224, AND VARIANT GLN-132.
RX   PubMed=1804413; DOI=10.1002/rcm.1290050410;
RA   Jones D.S., Heerma W., van Wassenaar P.D., Haverkamp J.;
RT   "Analysis of bovine beta-casein tryptic digest by continuous-flow fast-atom
RT   bombardment mass spectrometry.";
RL   Rapid Commun. Mass Spectrom. 5:192-195(1991).
RN   [12]
RP   PROTEIN SEQUENCE OF 41-45, AND FUNCTION.
RX   PubMed=15545057; DOI=10.1080/09629350400003068;
RA   Lebrun I., Cavallaro V., Juliano L., Juliano M.A., de Sousa e Silva M.C.C.;
RT   "Effects of 'casoparan', a peptide isolated from casein hydrolysates with
RT   mastoparan-like properties.";
RL   Mediators Inflamm. 13:263-268(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 48-63, AND VARIANT E LYS-51.
RX   PubMed=4411121; DOI=10.1016/0014-5793(74)80796-9;
RA   Grosclaude F., Mahe M.-F., Voglino G.-F.;
RT   "The beta E variant and the phosphorylation code of bovine caseins.";
RL   FEBS Lett. 45:3-5(1974).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 58-223.
RA   Otaviano A.R., Lima A.L.F., Laureano M.M.M., Albuquerque L.G., Tonhati H.,
RA   Sena J.A.D.;
RT   "Polymorphisms in beta and kappa casein genes in bubaline and bovine.";
RL   Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 58-223.
RA   Shahla M.N., Cheema F.R., Naeem M.K., Riazuddin S.;
RT   "Polymorphism in the cattle beta casein gene.";
RL   Submitted (MAY-2007) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 63-208.
RC   TISSUE=Mammary gland;
RA   Klotz A., Buchberger J., Krause I., Einspanier R.;
RT   "Characterization of milk proteins.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 68-105.
RX   PubMed=6397405; DOI=10.1016/0378-1119(84)90013-1;
RA   Ivanov V.N., Kershulite D.R., Bayev A.A., Akhundova A.A., Sulimova G.E.,
RA   Judinkova E.S., Gorodetsky S.I.;
RT   "Identification of bacterial clones encoding bovine caseins by direct
RT   immunological screening of the cDNA library.";
RL   Gene 32:381-388(1984).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 68-95.
RX   PubMed=3900695;
RA   Ivanov V.N., Kershulite D.R., Bayev A.A., Akhundova A.A., Silimova G.E.;
RT   "Identification of bacterial clones that encode cow's caseins by direct
RT   immunological screening of the cDNA library.";
RL   Mol. Biol. (Mosk.) 19:955-963(1985).
RN   [19]
RP   PROTEIN SEQUENCE OF 74-108, VARIANT LEU-108, PHOSPHORYLATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17720176; DOI=10.1016/j.chroma.2007.08.015;
RA   Schmelzer C.E.H., Schoeps R., Reynell L., Ulbrich-Hofmann R.,
RA   Neubert R.H.H., Raith K.;
RT   "Peptic digestion of beta-casein: Time course and fate of possible
RT   bioactive peptides.";
RL   J. Chromatogr. A 1166:108-115(2007).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 80-143, AND VARIANT LEU-108.
RA   Jann O., Ceriotti G., Caroli A., Erhardt G.;
RT   "A new variant in exon VII of bovine beta-casein gene (CSN2) and its
RT   contribution among European cattle breeds.";
RL   J. Anim. Breed. Genet. 119:65-68(2002).
RN   [21]
RP   PROTEIN SEQUENCE OF 113-120, FUNCTION, AND MASS SPECTROMETRY.
RA   Gupta A., Mann B., Kumar Bajaj R., Sangwan R.B.;
RT   "Studies on antioxidative peptides generated in cheddar cheese.";
RL   Submitted (JAN-2008) to UniProtKB.
RN   [22]
RP   PROTEIN SEQUENCE OF 118-124, AND VARIANT A3 GLN-121.
RX   PubMed=4997616;
RA   Ribadeau-Dumas B., Grosclaude F., Mercier J.-C.;
RT   "Localization in the peptide chain of bovine beta casein of the His-Gln
RT   substitution differentiating the A2 and A3 genetic variants.";
RL   C. R. Hebd. Seances Acad. Sci., D, Sci. Nat. 270:2369-2372(1970).
RN   [23]
RP   PROTEIN SEQUENCE OF 125-195 (VARIANTS A1 AND G).
RX   AGRICOLA=IND22004684; DOI=10.1016/S0958-6946(99)00019-9;
RA   Dong C., Ng-Kwai-Hang K.F.;
RT   "Characterization of a non-electrophoretic genetic variant of beta-casein
RT   by peptide mapping and mass spectrometric analysis.";
RL   Int. Dairy J. 8:967-972(1998).
RN   [24]
RP   PROTEIN SEQUENCE OF 129-136, FUNCTION, AND VARIANT GLN-132.
RX   PubMed=7600458; DOI=10.1139/y95-012;
RA   Lebrun I., Lebrun F.L.A.S., Henriques O.B., Carmona A.K., Juliano L.,
RA   Camargo A.C.M.;
RT   "Isolation and characterization of a new bradykinin potentiating
RT   octapeptide from gamma-casein.";
RL   Can. J. Physiol. Pharmacol. 73:85-91(1995).
RN   [25]
RP   PROTEIN SEQUENCE OF 129-136, AND FUNCTION.
RX   PubMed=14714726; DOI=10.1023/b:jopc.0000008724.98339.ff;
RA   Perpetuo E.A., Juliano L., Lebrun I.;
RT   "Biochemical and pharmacological aspects of two bradykinin-potentiating
RT   peptides obtained from tryptic hydrolysis of casein.";
RL   J. Protein Chem. 22:601-606(2003).
RN   [26]
RP   PROTEIN SEQUENCE OF 160-171 (VARIANT F).
RX   PubMed=7496485; DOI=10.1016/0021-9673(95)00058-u;
RA   Visser S., Slangen C.J., Lagerwerf F.M., Van Dongen W.D., Haverkamp J.;
RT   "Identification of a new genetic variant of bovine beta-casein using
RT   reversed-phase high-performance liquid chromatography and mass
RT   spectrometric analysis.";
RL   J. Chromatogr. A 711:141-150(1995).
RN   [27]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 170-184.
RX   PubMed=6897774; DOI=10.1089/dna.1982.1.375;
RA   Willis I.M., Stewart A.F., Caputo A., Thompson A.R., McKinlay A.G.;
RT   "Construction and identification by partial nucleotide sequence analysis of
RT   bovine casein and beta-lactoglobulin cDNA clones.";
RL   DNA 1:375-386(1982).
RN   [28]
RP   PHOSPHORYLATION AT SER-30; SER-32; SER-33; SER-34 AND SER-50, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16083266; DOI=10.1021/pr050113n;
RA   Wu S.L., Kim J., Hancock W.S., Karger B.;
RT   "Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS
RT   platform for high sequence coverage of complex proteins with extensive
RT   post-translational modifications-comprehensive analysis of beta-casein and
RT   epidermal growth factor receptor (EGFR).";
RL   J. Proteome Res. 4:1155-1170(2005).
RN   [29]
RP   PHOSPHORYLATION AT SER-30; SER-32; SER-33; SER-34 AND SER-50, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17510049; DOI=10.1074/mcp.m600480-mcp200;
RA   Imanishi S.Y., Kochin V., Ferraris S.E., de Thonel A., Pallari H.M.,
RA   Corthals G.L., Eriksson J.E.;
RT   "Reference-facilitated phosphoproteomics: fast and reliable phosphopeptide
RT   validation by micro LC-ESI-Q-TOF MS/MS.";
RL   Mol. Cell. Proteomics 6:1380-1391(2007).
RN   [30]
RP   VARIANTS A1; B AND C.
RX   PubMed=5064450; DOI=10.1111/j.1432-1033.1972.tb01771.x;
RA   Grosclaude F., Mahe M.-F., Mercier J.-C., Ribadeau-Dumas B.;
RT   "Characterization of genetic variants of alpha-S1 and beta bovine
RT   caseins.";
RL   Eur. J. Biochem. 26:328-337(1972).
CC   -!- FUNCTION: Important role in determination of the surface properties of
CC       the casein micelles.
CC   -!- FUNCTION: Casoparan acts as a macrophage activator, increasing the
CC       phagocytic activity of macrophages and peroxide release from
CC       macrophages. It also acts as a bradykinin-potentiating peptide.
CC   -!- FUNCTION: Casohypotensin acts as a bradykinin-potentiating peptide.
CC       Induces hypotension in rats. Acts as a strong competitive inhibitor of
CC       endo-oligopeptidase A.
CC   -!- FUNCTION: Antioxidant peptide has antioxidant activity.
CC   -!- INTERACTION:
CC       P02666; P0C0V0: degP; Xeno; NbExp=9; IntAct=EBI-5260183, EBI-547165;
CC       P02666; Q8IXL6: FAM20C; Xeno; NbExp=3; IntAct=EBI-5260183, EBI-7147442;
CC       P02666; O43464: HTRA2; Xeno; NbExp=7; IntAct=EBI-5260183, EBI-517086;
CC       P02666; PRO_0000026946 [O43464]: HTRA2; Xeno; NbExp=2; IntAct=EBI-5260183, EBI-5271862;
CC       P02666; P83110: HTRA3; Xeno; NbExp=8; IntAct=EBI-5260183, EBI-2867394;
CC       P02666; P83105: HTRA4; Xeno; NbExp=5; IntAct=EBI-5260183, EBI-21776319;
CC       P02666; P36776: LONP1; Xeno; NbExp=6; IntAct=EBI-5260183, EBI-357448;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Mammary gland specific. Secreted in milk.
CC   -!- MASS SPECTROMETRY: [Antioxidant peptide]: Mass=872.51;
CC       Method=Electrospray; Evidence={ECO:0000269|Ref.21};
CC   -!- POLYMORPHISM: Leu-152 is present in the variants F and G; Gln-190 and
CC       Glu-210 are present in the variant H. The sequence shown is the A2
CC       variant.
CC   -!- SIMILARITY: Belongs to the beta-casein family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAW84270.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAW84271.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=ABL74247.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Of buttons, digestion and
CC       glue - Issue 16 of November 2001;
CC       URL="https://web.expasy.org/spotlight/back_issues/016";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M15132; AAA30430.1; -; mRNA.
DR   EMBL; X06359; CAA29658.1; -; mRNA.
DR   EMBL; M16645; AAA30480.1; -; mRNA.
DR   EMBL; M55158; AAA30431.1; -; Genomic_DNA.
DR   EMBL; S67277; AAB29137.1; -; mRNA.
DR   EMBL; BC111172; AAI11173.1; -; mRNA.
DR   EMBL; AY899917; AAW84270.1; ALT_INIT; mRNA.
DR   EMBL; AY899918; AAW84271.1; ALT_INIT; mRNA.
DR   EMBL; AH007287; AAD09813.1; -; Genomic_DNA.
DR   EMBL; EF123100; ABL74247.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; EF628290; ABR10906.1; -; Genomic_DNA.
DR   EMBL; AJ296330; CAC37028.1; -; Genomic_DNA.
DR   EMBL; M64756; AAB59254.1; -; mRNA.
DR   EMBL; AY366419; AAR14677.1; -; Genomic_DNA.
DR   EMBL; K01087; AAA30481.1; -; mRNA.
DR   PIR; A59068; A59068.
DR   PIR; I45873; KBBOA2.
DR   AlphaFoldDB; P02666; -.
DR   DIP; DIP-46257N; -.
DR   IntAct; P02666; 7.
DR   MINT; P02666; -.
DR   STRING; 9913.ENSBTAP00000003409; -.
DR   BindingDB; P02666; -.
DR   ChEMBL; CHEMBL3313833; -.
DR   Allergome; 10199; Bos d 11.0101.
DR   Allergome; 167; Bos d 8.
DR   Allergome; 2736; Bos d 11.
DR   iPTMnet; P02666; -.
DR   PaxDb; P02666; -.
DR   PeptideAtlas; P02666; -.
DR   PRIDE; P02666; -.
DR   eggNOG; ENOG502RU0R; Eukaryota.
DR   HOGENOM; CLU_106775_0_0_1; -.
DR   InParanoid; P02666; -.
DR   OrthoDB; 1336883at2759; -.
DR   TreeFam; TF336929; -.
DR   PRO; PR:P02666; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0005615; C:extracellular space; IDA:AgBase.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:AgBase.
DR   GO; GO:0005796; C:Golgi lumen; IDA:AgBase.
DR   GO; GO:0016209; F:antioxidant activity; IEA:UniProtKB-KW.
DR   GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:CAFA.
DR   GO; GO:0008191; F:metalloendopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IDA:AgBase.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:AgBase.
DR   GO; GO:2000117; P:negative regulation of cysteine-type endopeptidase activity; IDA:CAFA.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:CAFA.
DR   GO; GO:1903720; P:negative regulation of I-kappaB phosphorylation; IDA:CAFA.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IDA:CAFA.
DR   GO; GO:1903488; P:negative regulation of lactation; IDA:AgBase.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IDA:CAFA.
DR   GO; GO:0008217; P:regulation of blood pressure; IEA:UniProtKB-KW.
DR   GO; GO:1903496; P:response to 11-deoxycorticosterone; IDA:AgBase.
DR   GO; GO:1903494; P:response to dehydroepiandrosterone; IDA:AgBase.
DR   GO; GO:0032355; P:response to estradiol; IDA:AgBase.
DR   GO; GO:0009408; P:response to heat; IDA:AgBase.
DR   GO; GO:0032570; P:response to progesterone; IDA:AgBase.
DR   DisProt; DP00329; -.
DR   InterPro; IPR001588; Casein.
DR   InterPro; IPR016345; Casein_beta.
DR   InterPro; IPR031305; Casein_CS.
DR   PANTHER; PTHR11500; PTHR11500; 1.
DR   Pfam; PF00363; Casein; 1.
DR   PIRSF; PIRSF002372; Beta-casein; 1.
DR   PROSITE; PS00306; CASEIN_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   Antioxidant; Direct protein sequencing; Hypotensive agent;
KW   Metalloenzyme inhibitor; Metalloprotease inhibitor; Milk protein;
KW   Phosphoprotein; Protease inhibitor; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..15
FT                   /evidence="ECO:0000269|PubMed:10690361,
FT                   ECO:0000269|PubMed:3278933, ECO:0000269|PubMed:4557764"
FT   CHAIN           16..224
FT                   /note="Beta-casein"
FT                   /id="PRO_0000004470"
FT   PEPTIDE         41..45
FT                   /note="Casoparan"
FT                   /id="PRO_0000292031"
FT   PEPTIDE         113..120
FT                   /note="Antioxidant peptide"
FT                   /id="PRO_0000320153"
FT   PEPTIDE         129..136
FT                   /note="Casohypotensin"
FT                   /id="PRO_0000308464"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16083266,
FT                   ECO:0000269|PubMed:17510049, ECO:0000269|PubMed:4557764"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16083266,
FT                   ECO:0000269|PubMed:17510049, ECO:0000269|PubMed:4557764"
FT   MOD_RES         33
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16083266,
FT                   ECO:0000269|PubMed:17510049, ECO:0000269|PubMed:4557764"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16083266,
FT                   ECO:0000269|PubMed:17510049, ECO:0000269|PubMed:4557764"
FT   MOD_RES         50
FT                   /note="Phosphoserine; in variant A1, variant A2, variant
FT                   A3, variant B, variant E, variant F, variant G and variant
FT                   H"
FT                   /evidence="ECO:0000269|PubMed:16083266,
FT                   ECO:0000269|PubMed:17510049"
FT   VARIANT         33
FT                   /note="S -> K (in variant D)"
FT                   /evidence="ECO:0000269|PubMed:10690361"
FT   VARIANT         40
FT                   /note="R -> C (in variant H)"
FT   VARIANT         51
FT                   /note="E -> K (in variant E)"
FT                   /evidence="ECO:0000269|PubMed:4411121"
FT   VARIANT         52
FT                   /note="E -> K (in variant C)"
FT   VARIANT         82
FT                   /note="P -> H (in variants A1, B, C, F and G)"
FT                   /evidence="ECO:0000269|PubMed:3271384, ECO:0000269|Ref.2,
FT                   ECO:0000269|Ref.6"
FT   VARIANT         103
FT                   /note="L -> I (in variant H)"
FT   VARIANT         108
FT                   /note="M -> L"
FT                   /evidence="ECO:0000269|PubMed:17720176,
FT                   ECO:0000269|PubMed:3814153, ECO:0000269|PubMed:4557764,
FT                   ECO:0000269|Ref.20"
FT   VARIANT         121
FT                   /note="H -> Q (in variant A3)"
FT                   /evidence="ECO:0000269|PubMed:4997616,
FT                   ECO:0000269|PubMed:8248100"
FT   VARIANT         132
FT                   /note="E -> Q (in variants A1 and G)"
FT                   /evidence="ECO:0000269|PubMed:1804413,
FT                   ECO:0000269|PubMed:7600458"
FT   VARIANT         137
FT                   /note="S -> R (in variant B)"
FT                   /evidence="ECO:0000269|Ref.6"
FT   VARIANT         152
FT                   /note="L -> P (in variants A1 and H)"
FT                   /evidence="ECO:0000269|PubMed:3814153"
FT   VARIANT         153
FT                   /note="P -> L (in variants A1, G and H)"
FT                   /evidence="ECO:0000269|PubMed:3814153"
FT   VARIANT         167
FT                   /note="P -> L (in variant F)"
FT   VARIANT         190
FT                   /note="Q -> E (in variants A1 and G)"
FT   CONFLICT        50
FT                   /note="S -> Z (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        69
FT                   /note="Q -> R (in Ref. 14; ABL74247)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        112
FT                   /note="K -> R (in Ref. 14; ABL74247)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        208
FT                   /note="Y -> V (in Ref. 16; CAC37028)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        209..210
FT                   /note="QE -> EQ (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        210
FT                   /note="E -> Q (in Ref. 1; AAA30430 and 8; no nucleotide
FT                   entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212
FT                   /note="V -> A (in Ref. 15; ABR10906)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   224 AA;  25107 MW;  F0BBDD8148A238AE CRC64;
     MKVLILACLV ALALARELEE LNVPGEIVES LSSSEESITR INKKIEKFQS EEQQQTEDEL
     QDKIHPFAQT QSLVYPFPGP IPNSLPQNIP PLTQTPVVVP PFLQPEVMGV SKVKEAMAPK
     HKEMPFPKYP VEPFTESQSL TLTDVENLHL PLPLLQSWMH QPHQPLPPTV MFPPQSVLSL
     SQSKVLPVPQ KAVPYPQRDM PIQAFLLYQE PVLGPVRGPF PIIV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024